Literature DB >> 3302116

Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid alpha-glucosidase.

A T van der Ploeg, M Kroos, J M van Dongen, W J Visser, P A Bolhuis, M C Loonen, A J Reuser.   

Abstract

Fibroblast cultures from patients with different clinical subtypes of glycogenosis type II were compared with respect to residual acid alpha-glucosidase activity and lysosomal glycogen content. Lysosomal glycogen storage was most pronounced in fibroblasts from patients with the rapidly progressive infantile form of the disease, and the most severe enzyme deficiency. In fibroblasts from adult patients with more than 10% of the control activity storage did not occur, and 15% of the total cellular glycogen was found in the lysosomes as in control cells. The strict correlation between residual acid alpha-glucosidase activity and lysosomal glycogen accumulation was further illustrated in two adult Pompe patients with an unusually low enzyme activity. The mild clinical course is unexplained in these particular cases. The enzyme deficiency in all the different mutant cell lines was corrected by the uptake of bovine testis acid alpha-glucosidase from the culture medium. As a result of this, the lysosomal glycogen storage disappeared, and the balance between lysosomal and cytoplasmic glycogen was restored to normal. The implications of this study as a model for enzyme replacement therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3302116     DOI: 10.1016/0022-510x(87)90239-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells.

Authors:  A T van der Ploeg; P A Bolhuis; R A Wolterman; J W Visser; M C Loonen; H F Busch; A J Reuser
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

2.  Correction of glycogenosis type 2 by muscle-specific lentiviral vector.

Authors:  Emmanuel Richard; Gaëlle Douillard-Guilloux; Lionel Batista; Catherine Caillaud
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-09-23       Impact factor: 2.416

3.  Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice.

Authors:  A T Van der Ploeg; M A Kroos; R Willemsen; N H Brons; A J Reuser
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  Glycogenosis type II: protein and DNA analysis in five South African families from various ethnic origins.

Authors:  A T Van der Ploeg; L H Hoefsloot; M Hoogeveen-Westerveld; E M Petersen; A J Reuser
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

5.  GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells.

Authors:  Erik van der Wal; Atze J Bergsma; Tom J M van Gestel; Stijn L M In 't Groen; Holm Zaehres; Marcos J Araúzo-Bravo; Hans R Schöler; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Mol Ther Nucleic Acids       Date:  2017-03-14

6.  Satellite cells maintain regenerative capacity but fail to repair disease-associated muscle damage in mice with Pompe disease.

Authors:  Gerben J Schaaf; Tom J M van Gestel; Stijn L M In 't Groen; Bart de Jong; Björn Boomaars; Antonietta Tarallo; Monica Cardone; Giancarlo Parenti; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Acta Neuropathol Commun       Date:  2018-11-07       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.